Company page

United Therapeutics Corporation

United Therapeutics Corporation, traded under the ticker UTHR, is a public company based in the United States with a market capitalization of approximately $22.43 billion. The company focuses on innovative therapies for the treatment of chronic and life-threatening conditions. United Therapeutics is committed to advancing healthcare solutions and improving patient outcomes through its research and development efforts.